⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13121336 | 1.00 | — | — | |
| SCHEMBL12819875 | 1.00 | — | — | |
| SCHEMBL12830317 | 1.00 | — | — | |
| SCHEMBL10282194 | 1.00 | — | — | |
| SCHEMBL14642428 | 1.00 | — | — | |
| SCHEMBL13191561 | 1.00 | — | — | |
| SCHEMBL18823628 | 1.00 | — | — | |
| SCHEMBL21134094 | 1.00 | — | — | |
| SCHEMBL20613792 | 1.00 | — | — | |
| SCHEMBL14712370 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230232878-A1 | COMPOSITIONS COMPRISING REBAUDIOSIDE J | PEPSICO, INC. (US) | 2023-07-27 | — | — | US | disclosed |
| WO-2018106644-A1 | ß-1,6-GLUCAN TRASTUZUMAB ANTIBODY CONJUGATES | INNATE BIOTHERAPEUTICS, LLC (US) | 2018-06-14 | — | — | WO | disclosed |
| US-20180016291-A1 | Rebaudioside Analogs | PEPSICO, INC. | 2018-01-18 | — | — | US | disclosed |